A requirement for FcγR in antibody-mediated bacterial toxin neutralization

Journal of Experimental Medicine

Volumn 207, Issue 11, 2010, Pages 2395-2405

  Abboud, Nareen ^a   Chow, Siu Kei ^a   Saylor, Carolyn ^a   Janda, Alena ^a   Ravetch, Jeffery V ^b   Scharff, Matthew D ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIAL TOXIN; CYTOCHALASIN D; FC RECEPTOR; FC RECEPTOR IIB; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BACILLUS ANTHRACIS; BINDING AFFINITY; CYTOTOXICITY; IMMUNIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; UPREGULATION;

ANIMALS; ANTHRAX VACCINES; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELL LINE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; RECEPTORS, IGG;

EID: 78149323035     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100995     Document Type: Article

References (53)

1. Abboud, N., and A. Casadevall. 2008. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clin. Vaccine Immunol. 15:1115-1123. doi:10.1128/CVI.00015-08 (Pubitemid 352018319)
2. Abboud, N., M. De Jesus, A. Nakouzi, R.J. Cordero, M. Pujato, A. Fiser, J. Rivera, and A. Casadevall. 2009. Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. J. Biol. Chem. 284:25077-25086. doi:10.1074/jbc.M109.022061
3. Abrami, L., S. Liu, P. Cosson, S.H. Leppla, and F.G. van der Goot. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160:321-328. doi:10.1083/jcb.200211018 (Pubitemid 36182723)
4. Abrami, L., M. Lindsay, R.G. Parton, S.H. Leppla, and F.G. van der Goot. 2004. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J. Cell Biol. 166:645-651. doi:10.1083/jcb.200312072
5. Aderem, A., and D.M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623. doi:10.1146/annurev.immunol.17.1. 593
6. Baldridge, J.R., and M.J. Buchmeier. 1992. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 66:4252-4257.
7. Bonuccelli, G., F. Sotgia, P.G. Frank, T.M. Williams, C.J. de Almeida, H.B. Tanowitz, P.E. Scherer, K.A. Hotchkiss, B.I. Terman, B. Rollman, et al. 2005. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am. J. Physiol. Cell Physiol. 288:C1402-C1410. doi:10.1152/ajpcell. 00582.2004
8. Bradley, K.A., J. Mogridge, M. Mourez, R.J. Collier, and J.A. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature. 414:225-229. doi:10.1038/n35101999
9. Casadevall, A., J. Mukherjee, and M.D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods. 154:27-35. doi:10.1016/0022-1759(92)90209-C
10. Chopra, A.P., S.A. Boone, X. Liang, and N.S. Duesbery. 2003. Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 278:9402-9406. doi:10.1074/jbc.M211262200
11. Daëron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15:203-234. doi:10.1146/annurev.immunol.15.1.203
12. De Jesus, M., A.M. Nicola, M.L. Rodrigues, G. Janbon, and A. Casadevall. 2009. Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan. Eukaryot. Cell. 8:96-103. doi:10.1128/EC.00331-08
13. Duesbery, N.S., C.P. Webb, S.H. Leppla, V.M. Gordon, K.R. Klimpel, T.D. Copeland, N.G. Ahn, M.K. Oskarsson, K. Fukasawa, K.D. Paull, and G.F. Vande Woude. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science. 280:734-737. doi:10.1126/science.280.5364.734
14. Furriel, R.P., Y.M. Lucisano, and B. Mantovani. 1992. Precipitated immune complexes of IgM as well as of IgG can bind to rabbit polymorphonuclear leucocytes but only the immune complexes of IgG are readily phagocytosed. Immunology. 75:528-534.
15. Gordon, V.M., S.H. Leppla, and E.L. Hewlett. 1988. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect. Immun. 56:1066-1069.
16. Greene, G., J. Hodous, R.Z. Dintzis, and H.M. Dintzis. 1990. Modification, optimization and simplification of the spot ELISA technique for the enumeration of cells secreting anti-hapten antibodies. J. Immunol. Methods. 129:187-197. doi:10.1016/0022-1759(90)90438-2
17. Harvill, E.T., M. Osorio, C.L. Loving, G.M. Lee, V.K. Kelly, and T.J. Merkel. 2008. Anamnestic protective immunity to Bacillus anthracis is antibody mediated but independent of complement and Fc receptors. Infect. Immun. 76:2177-2182. doi:10.1128/IAI.00647-07
18. Hulett, M.D., E. Witort, R.I. Brinkworth, I.F. McKenzie, and P.M. Hogarth. 1994. Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. J. Biol. Chem. 269:15287-15293. (Pubitemid 24198379)
19. Kaneko, Y., F. Nimmerjahn, M.P. Madaio, and J.V. Ravetch. 2006. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 203:789-797. doi:10.1084/jem.20051900
20. Klimpel, K.R., N. Arora, and S.H. Leppla. 1994. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity. Mol. Microbiol. 13:1093-1100. doi:10.1111/j.1365-2958. 1994.tb00500.x
21. Koval, M., K. Preiter, C. Adles, P.D. Stahl, and T.H. Steinberg. 1998. Size of IgG-opsonized particles determines macrophage response during internalization. Exp. Cell Res. 242:265-273. doi:10.1006/excr.1998.4110
22. Kurosaki, T., I. Gander, and J.V. Ravetch. 1991. A subunit common to an IgG Fc receptor and the T-cell receptor mediates assembly through different interactions. Proc. Natl. Acad. Sci. USA. 88:3837-3841. doi:10.1073/pnas.88.9. 3837
23. Laffly, E., L. Danjou, F. Condemine, D. Vidal, E. Drouet, M.P. Lefranc, C. Bottex, and P. Thullier. 2005. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob. Agents Chemother. 49:3414-3420. doi:10.1128/AAC.49.8.3414-3420.2005
24. Little, S.F., B.E. Ivins, P.F. Fellows, and A.M. Friedlander. 1997. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect. Immun. 65:5171-5175.
25. Mabry, R., M. Rani, R. Geiger, G.B. Hubbard, R. Carrion Jr., K. Brasky, J.L. Patterson, G. Georgiou, and B.L. Iverson. 2005. Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect. Immun. 73:8362-8368. doi:10.1128/IAI.73.12.8362-8368.2005
26. Markine-Goriaynoff, D., X. Hulhoven, C.L. Cambiaso, P. Monteyne, T. Briet, M.D. Gonzalez, P. Coulie, and J.P. Coutelier. 2002. Natural killer cell activation after infection with lactate dehydrogenase-elevating virus. J. Gen. Virol. 83:2709-2716.
27. Maynard, J.A., C.B. Maassen, S.H. Leppla, K. Brasky, J.L. Patterson, B.L. Iverson, and G. Georgiou. 2002. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol. 20:597-601. doi:10.1038/nbt0602-597
28. Mellman, I., H. Plutner, and P. Ukkonen. 1984. Internalization and rapid recycling of macrophage Fc receptors tagged with monovalent antireceptor antibody: possible role of a prelysosomal compartment. J. Cell Biol. 98:1163-1169. doi:10.1083/jcb.98.4.1163
29. Moayeri, M., N.W. Martinez, J. Wiggins, H.A. Young, and S.H. Leppla. 2004. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 72:4439-4447. doi:10.1128/IAI.72.8.4439-4447.2004
30. Mohamed, N., J. Li, C.S. Ferreira, S.F. Little, A.M. Friedlander, G.L. Spitalny, and L.S. Casey. 2004. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect. Immun. 72:3276-3283. doi:10.1128/IAI.72.6.3276-3283.2004
31. Muehlbauer, S.M., T.H. Evering, G. Bonuccelli, R.C. Squires, A.W. Ashton, S.A. Porcelli, M.P. Lisanti, and J. Brojatsch. 2007. Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis. Cell Cycle. 6:758-766.
32. Nimmerjahn, F., and J.V. Ravetch. 2006. Fcgamma receptors: old friends and new family members. Immunity. 24:19-28. doi:10.1016/j.immuni.2005.11.010
33. Nimmerjahn, F., P. Bruhns, K. Horiuchi, and J.V. Ravetch. 2005. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity. 23:41-51. doi:10.1016/j.immuni.2005.05.010
34. Ra, C., M.H. Jouvin, U. Blank, and J.P. Kinet. 1989. A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit. Nature. 341:752-754. doi:10.1038/341752a0
35. Ravetch, J.V. 1997. Fc receptors. Curr. Opin. Immunol. 9:121-125. doi:10.1016/S0952-7915(97)80168-9
36. Ravetch, J.V., and J.P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9:457-492.
37. Reuveny, S., M.D. White, Y.Y. Adar, Y. Kafri, Z. Altboum, Y. Gozes, D. Kobiler, A. Shafferman, and B. Velan. 2001. Search for correlates of protective immunity conferred by anthrax vaccine. Infect. Immun. 69:2888-2893. doi:10.1128/IAI.69.5.2888-2893.2001
38. Rivera, J., A. Nakouzi, N. Abboud, E. Revskaya, D. Goldman, R.J. Collier, E. Dadachova, and A. Casadevall. 2006. A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1. Infect. Immun. 74:4149-4156. doi:10.1128/IAI.00150-06
39. Schaeffer, H.J., and M.J. Weber. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:2435-2444.
40. Scobie, H.M., G.J. Rainey, K.A. Bradley, and J.A. Young. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA. 100:5170-5174. doi:10.1073/pnas.0431098100
41. Spira, G., and M.D. Scharff. 1992. Identification of rare immunoglobulin switch variants using the ELISA spot assay. J. Immunol. Methods. 148:121-129. doi:10.1016/0022-1759(92)90165-P
42. Spira, G., A. Bargellesi, J.L. Teillaud, and M.D. Scharff. 1984. The identification of monoclonal class switch variants by sib selection and an ELISA assay. J. Immunol. Methods. 74:307-315. doi:10.1016/0022-1759(84)90298-9 (Pubitemid 15222190)
43. Spira, G., P. Gregor, H.L. Aguila, and M.D. Scharff. 1994. Clonal variants of hybridoma cells that switch isotype at a high frequency. Proc. Natl. Acad. Sci. USA. 91:3423-3427. doi:10.1073/pnas.91.8.3423
44. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J.V. Ravetch. 1994. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 76:519-529. doi:10.1016/0092-8674(94)90115-5 (Pubitemid 24064172)
45. Torres, M., and A. Casadevall. 2008. The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol. 29:91-97. doi:10.1016/j.it.2007.11.004
46. Verma, A., M.M. Ngundi, B.D. Meade, R. De Pascalis, K.L. Elkins, and D.L. Burns. 2009. Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin. Vaccine Immunol. 16:1405-1412. doi:10.1128/CVI.00194-09
47. Vitale, G., R. Pellizzari, C. Recchi, G. Napolitani, M. Mock, and C. Montecucco. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-711. doi:10.1006/bbrc.1998.9040
48. Vitale, L., D. Blanset, I. Lowy, T. O'Neill, J. Goldstein, S.F. Little, G.P. Andrews, G. Dorough, R.K. Taylor, and T. Keler. 2006. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Infect. Immun. 74:5840-5847. doi:10.1128/IAI.00712-06
49. von Behring, E., and S. Kitasato. 1991. [The mechanism of diphtheria immunity and tetanus immunity in animals. 1890]. Mol. Immunol. 28:1317:1319-1320. doi:10.1016/0161-5890(91)90032-F
50. Wang, J.Y., and M.H. Roehrl. 2005. Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin. Med. Immunol. 4:4. doi:10.1186/1476-9433-4-4
51. Welkos, S.L., T.J. Keener, and P.H. Gibbs. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51:795-800.
52. Wild, M.A., H. Xin, T. Maruyama, M.J. Nolan, P.M. Calveley, J.D. Malone, M.R. Wallace, and K.S. Bowdish. 2003. Human antibodies from immunized donors are protective against anthrax toxin in vivo. Nat. Biotechnol. 21:1305-1306. doi:10.1038/nbt891
53. Wirthmueller, U., T. Kurosaki, M.S. Murakami, and J.V. Ravetch. 1992. Signal transduction by Fc gamma RIII (CD16) is mediated through the gamma chain. J. Exp. Med. 175:1381-1390. doi:10.1084/jem.175.5.1381